Head, Sanofi Genzyme Business Development and Licensing
Cambridge Cambridge UNITED STATES
Adam Keeney joined Sanofi in January 2014 and he currently leads the Sanofi Genzyme Business Development teams. This group is responsible for the search, assessment & transactions activities supporting each of Sanofi’s specialty care therapeutic areas, which include Oncology, Immunology, Rare Diseases, Neurology & MS. As chair of the External Investment Committee, Adam oversees the review, prioritization and execution of all external R&D investments, as well as management of the External Research budget. Adam is based in Cambridge, Massachusetts. Before joining Sanofi, Adam worked at Johnson & Johnson, with his most recent role at the J&J California Innovation Center, in charge of setting the Innovation Center vision, mission, goals and objectives. Prior to this position, Adam held roles of increasing responsibility with the J&J Pharmaceuticals Business Development Group after starting is career at H. Lundbeck A/S in Copenhagen, Denmark. Adam holds a PhD in Neuropharmacology from the University of Nottingham, UK.
None yet.